StockWatch
·

RECURSION PHARMACEUTICALS, INC. Q3 FY25 Results

RXRXQ3 FY25 Results
Filing
MetricValue ($ M)Q2 FY25Q3 FY24
Revenue5.1873.0%80.1%
Total Income5.1873.0%80.1%
Expenditure177.389.3%42.5%
PBT-162.255.6%69.6%
Net Profit-162.255.6%69.3%
OPM—
NPM—
EPS-0.3612.2%5.9%
View full financials

Informational and educational content only. Not investment advice.